Exponent price to book ratio EXPO
Market value divided by the book value of the company's net assets, since 2011.
- Today, Oct 23, 2026
- 12.8×
- 10-year median
- 10.8×
- Against its 10-year history
- 72nd
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 5.2× to 17.6×
- Peer median
- 3.1×
Exponent's price to book ratio is 12.8× as of Oct 23, 2026.
That is above its ten-year median of 10.8×, higher than on 72% of days in the last ten years.
Over that time it ranged from 5.2× in Jun 2017 to 17.6× in Feb 2023.
The median for 8 consulting Services stocks of a similar size is 3.1×.
Price to book ratio over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 12.8× | 7.7× | 12.8× |
| 2025 | 8.8× | 7.7× | 11.4× |
| 2024 | 11.1× | 11.1× | 14.8× |
| 2023 | 12.6× | 10.4× | 17.6× |
| 2022 | 15.7× | 10.9× | 16.4× |
| 2021 | 15.0× | 11.9× | 16.1× |
| 2020 | 13.5× | 8.9× | 13.5× |
| 2019 | 10.1× | 7.9× | 10.8× |
| 2018 | 7.9× | 6.2× | 8.9× |
| 2017 | 6.1× | 5.2× | 6.7× |
| 2016 | 5.8× | 4.5× | 6.2× |
| 2015 | 5.0× | 4.2× | 5.4× |
| 2014 | 4.4× | 3.7× | 4.4× |
| 2013 | 4.5× | 3.1× | 4.7× |
| 2012 | 3.4× | 3.1× | 3.9× |
| 2011 | 3.4× | 2.7× | 3.6× |
Against its peers
Companies in Consulting Services nearest Exponent's size, closest first, today.
| Company | Price to book ratio |
|---|---|
| EXPOExponent | 12.8× |
| FCNFTI Consulting | 3.3× |
| HURNHuron Consulting | 8.1× |
| ASTHAstrana Health | 2.5× |
| GGenpact LTD | 2.6× |
| ICFIICF International | 1.6× |
| BAHBooz Allen Hamilton | 7.8× |
| BWMNBowman Consulting | 2.9× |
| EFXEquifax | 4.9× |
| Peer median | 3.1× |
What the price to book ratio tells you
Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.
Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.
More on Exponent
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.